Publications by authors named "Jinle Tang"

Claim this Profile
I
Identification of Small Molecule Inhibitors of RNase L by Fragment-Based Drug Discovery.
Jinle Tang, Beihua Dong, Ming Liu, Shuyan Liu, Xiaogang Niu

J Med Chem· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease.
Yunxia Xu, Ke Chen, Juanli Pan, Yingshou Lei, Danting Zhang, Jinle Tang

Int J Biol Macromol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.
Ziyang Fu, Bin Huang, Jinle Tang, Shuyan Liu, Ming Liu

Nat Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency.
Salima Daou, Manisha Talukdar, Jinle Tang, Beihua Dong, Shuvojit Banerjee

Proc Natl Acad Sci U S A· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib inhibits RNase L by destabilizing its active dimer conformation.
Jinle Tang, Yingjie Wang, Huan Zhou, Yuxin Ye, Manisha Talukdar

Biochem J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HMGB1 Promotes Mitochondrial Dysfunction-Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation.
Lin Qi, Xue Sun, Feng-E Li, Bao-Song Zhu, Frank K Braun, Jin-Le Tang

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells.
Jinle Tang, Jialu Li, Xuejun Zhu, Yuan Yu, Dan Chen

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling.
Xing-Ding Zhang, Veerabhadran Baladandayuthapani, Heather Lin, George Mulligan, Bin Li, Jin-Le Tang

Cancer Cell· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma.
Jianxuan Zou, Dan Chen, Yunhui Zong, Sisi Ye, Jinle Tang

Cancer Sci· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis